Is the priority review voucher program stimulating new drug development for tropical diseases?

E-resources

PDF

Full text

Peer reviewed Open access

Is the priority review voucher program stimulating new drug development for tropical diseases?

Kerr, Kirk W; Henry, Thomas C; Miller, Kathleen L

PLoS neglected tropical diseases, 08/2018, Volume: 12, Issue: 8

Journal Article

Congress created the tropical disease priority review voucher program to stimulate new drug development for tropical diseases. An analysis of the pharmaceutical pipeline indicates that the development of drugs for these tropical diseases has increased. However, the effects of the program are not uniform across all diseases, as malaria and tuberculosis have seen significant new drug development, while other diseases have not.

Keep searching

Author

Kerr, Kirk W | Henry, Thomas C | Miller, Kathleen L

Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.

Year	Impact factor		Edition		Category		Classification
Year	JCR	SNIP	JCR	SNIP	JCR	SNIP	JCR	SNIP

Links to authors' personal bibliographies	Links to information on researchers in the SICRIS system

Source: Personal bibliographies and: SICRIS

Upload image

Shelf entry

Adding material to shelf was successful.

Adding material to shelf failed.

It was not necessary to add the material to the shelf.

Permalink

E-mail

Impact factor

Select the library membership card:

DRS, in which the journal is indexed

Citations

Theme